Skip to main content

Table 7 Univariate analysis of ER-positive cases with adjuvant hormonal

From: Association of GATA3, P53, Ki67 status and vascular peritumoral invasion are strongly prognostic in luminal breast cancer

Variable

NE (%)

Classes

N (%)

Hazard Ratio [IC95]

p-value ×

Age

0 (0%)

< 45 years

29 (8%)

1

0.964

  

>= 45 years

355 (92%)

1.02 [0.401–2.605]

 
  

< 45

29 (8%)

1

0.315

  

45–60

155 (40%)

0.834 [0.312–2.226]

 
  

> 60

200 (52%)

1.32 [0.493–3.522]

 

Tumoral size

2 (1%)

< 25 mm

141 (37%)

1

0.0222

  

>= 25 mm

241 (63%)

2.16 [1.1–4.23]

 

Scarff-Bloom-Richardson grade

2 (1%)

I

141 (37%)

1

0.000487

  

II–III

241 (63%)

4.1 [1.74–9.644]

 

VPI

3 (1%)

absent

237 (62%)

1

0.00363

  

present

144 (38%)

2.36 [1.305–4.268]

 

N

3 (1%)

N-

174 (46%)

1

0.0495

  

N+

207 (54%)

2.22 [1–4.921]

 
  

N < 3

288 (76%)

1

< 0.0001

  

N >= 3

93 (24%)

3.81 [2.113–6.883]

 

AR

66 (17%)

0

74 (23%)

1

0.306

  

> 0

244 (77%)

0.712 [0.371–1.369]

 

BCL2

66 (17%)

0

38 (12%)

1

0.0676

  

> 0

280 (88%)

0.492 [0.226–1.069]

 

CCND1

47 (12%)

0

97 (29%)

1

0.971

  

> 0

240 (71%)

1.01 [0.542–1.886]

 

ERBB2

36 (9%)

1 or 2

319 (92%)

1

0.558

  

2 or 3

29 (8%)

1.32 [0.519–3.359]

 

FOXA1

78 (20%)

0

3 (1%)

1

0.406

  

> 0

303 (99%)

9220000 [0-Inf]

 

GATA3

66 (17%)

0

70 (22%)

1

0.0952

  

> 0

248 (78%)

0.599 [0.326–1.1]

 

Ki67

60 (16%)

< 20

299 (92%)

1

0.000304

  

>= 20

25 (8%)

3.58 [1.709–7.488]

 

P53

55 (14%)

0

272 (83%)

1

< 0001

  

> 0

57 (17%)

3.13 [1.745–5.601]

 

ER

0 (0%)

< 120

153 (40%)

1

0.227

  

>= 120

231 (60%)

0.71 [0.406–1.24]

 

PR

44 (11%)

0

76 (22%)

1

0.941

  

> 0

264 (78%)

0.975 [0.499–1.904]

 
  1. NE: non evaluable cases on Tissu-micro arrays. × Logrank test stratified on chemotherapy.